International Workshop on HIV and Hepatitis Virus Drug Resistance and Curative Strategies, 4-8 June 2013, Toronto
This annual meeting had developed from its previous focus on HIV drug resistance to include resistance to hepatitis C and developments in cure research.
The meeting has a diverse and interesting programme and the organisers helpfully post the programme, abstract books and links to some of the oral presentations online.
Reports in this issue of HTB include:
- Higher intracellular concentrations with tenofovir alafenamide (TAF) overcomes K65R and other key NRTI resistance in vitro
- Tentative phenotypic cut offs for dolutegravir: guidance for use with integrase resistance
- S/GSK744 and long-acting formulation indicate broadly similar resistance profile to dolutegravir
- One in five people with recent HIV infection in Spain have X4/R5 mixed tropic virus